Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci-Reference-Cited by-同舟云学术

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

Published:2010-12-12 Issue:1 Volume:43 Page:17-19
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Melum Espen,Franke Andre,Schramm Christoph,Weismüller Tobias J,Gotthardt Daniel Nils,Offner Felix A,Juran Brian D,Laerdahl Jon K,Labi Verena,Björnsson Einar,Weersma Rinse K,Henckaerts Liesbet,Teufel Andreas,Rust Christian,Ellinghaus Eva,Balschun Tobias,Boberg Kirsten Muri,Ellinghaus David,Bergquist Annika,Sauer Peter,Ryu Euijung,Hov Johannes Roksund,Wedemeyer Jochen,Lindkvist Björn,Wittig Michael,Porte Robert J,Holm Kristian,Gieger Christian,Wichmann H-Erich,Stokkers Pieter,Ponsioen Cyriel Y,Runz Heiko,Stiehl Adolf,Wijmenga Cisca,Sterneck Martina,Vermeire Severine,Beuers Ulrich,Villunger Andreas,Schrumpf Erik,Lazaridis Konstantinos N,Manns Michael P,Schreiber Stefan,Karlsen Tom H

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.728.pdf

Reference10 articles.

1. Broomé, U. & Bergquist, A. Semin. Liver Dis. 26, 31–41 (2006).

2. Karlsen, T.H. et al. Gastroenterology 138, 1102–1111 (2010).

3. Zhernakova, A., van Diemen, C.C. & Wijmenga, C. Nat. Rev. Genet. 10, 43–55 (2009).

4. Bergquist, A. et al. Clin. Gastroenterol. Hepatol. 6, 939–943 (2008).

5. Karlsen, T.H., Melum, E. & Franke, A. Hepatology 51, 1833–1842 (2010).

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage-Stimulating 1 Polymorphism rs3197999 in Pediatric Patients with Inflammatory Bowel Disease;Medicina;2024-07-31

2. Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis;Cell Reports Medicine;2024-07

3. Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis;BMC Medical Genomics;2024-06-11

4. Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review;eGastroenterology;2024-03

5. Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis;Clinics in Liver Disease;2024-02